No connection

Search Results

ITGR vs JNJ

ITGR
Integer Holdings Corporation
NEUTRAL
Price
$84.64
Market Cap
$2.91B
Sector
Healthcare
AI Confidence
85%
JNJ
Johnson & Johnson
NEUTRAL
Price
$237.96
Market Cap
$573.46B
Sector
Healthcare
AI Confidence
85%

Valuation

P/E Ratio
ITGR
29.29
JNJ
21.55
Forward P/E
ITGR
11.71
JNJ
18.9
P/B Ratio
ITGR
1.66
JNJ
7.03
P/S Ratio
ITGR
1.57
JNJ
6.09
EV/EBITDA
ITGR
11.17
JNJ
17.81

Profitability

Gross Margin
ITGR
27.39%
JNJ
68.08%
Operating Margin
ITGR
12.79%
JNJ
23.97%
Profit Margin
ITGR
5.55%
JNJ
28.46%
ROE
ITGR
6.11%
JNJ
35.03%
ROA
ITGR
4.75%
JNJ
8.68%

Growth

Revenue Growth
ITGR
5.0%
JNJ
9.1%
Earnings Growth
ITGR
52.9%
JNJ
48.6%

Financial Health

Debt/Equity
ITGR
0.75
JNJ
0.6
Current Ratio
ITGR
3.32
JNJ
1.03
Quick Ratio
ITGR
2.05
JNJ
0.69

Dividends

Dividend Yield
ITGR
--
JNJ
2.19%
Payout Ratio
ITGR
0.0%
JNJ
46.6%

AI Verdict

ITGR NEUTRAL

Integer Holdings (ITGR) presents a dichotomy between strong forward-looking earnings potential and weak current market sentiment. The Piotroski F-Score of 4/9 indicates stable but not robust financial health, while the stock is currently trading almost exactly at its growth-based intrinsic value of $85.26, leaving no margin of safety. While the trailing P/E is high, the Forward P/E of 11.71 and explosive YoY earnings growth of 52.9% suggest a significant valuation correction is underway. However, a bearish technical trend and negative insider sentiment temper the bullish analyst consensus.

Strengths
Exceptional short-term liquidity with a Current Ratio of 3.32
Strong earnings acceleration with 52.9% YoY growth
Attractive Forward P/E (11.71) compared to trailing P/E (29.29)
Risks
Lack of margin of safety as price ($84.64) equals intrinsic value ($85.26)
Stagnant revenue growth (5% YoY) suggesting earnings growth is driven by cost-cutting rather than expansion
Bearish technical trend (0/100) and negative insider sentiment
JNJ NEUTRAL

JNJ presents a dichotomy between strong profitability and deteriorating fundamental health, evidenced by a weak Piotroski F-Score of 3/9. While the company maintains an impressive ROE of 35.03% and a consistent history of earnings beats, the current price of $237.96 trades at a significant premium to its Graham Number of $91.72. Growth remains robust on a YoY basis, but bearish insider sentiment and a very weak technical trend (10/100) suggest immediate headwinds. The stock is fundamentally sound in terms of earnings power but shows signs of operational inefficiency or declining quality in its deterministic health metrics.

Strengths
Exceptional Return on Equity (ROE) of 35.03%
Strong profit margins (28.46%) and gross margins (68.08%)
Consistent earnings beat track record over 25 quarters
Risks
Weak Piotroski F-Score (3/9) indicating declining fundamental health
Bearish insider activity with $58.35M in net sales and zero buys
Low liquidity indicated by a Quick Ratio of 0.69

Compare Another Pair

ITGR vs JNJ: Head-to-Head Comparison

This page compares Integer Holdings Corporation (ITGR) and Johnson & Johnson (JNJ) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.

Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.

Home
Terminal
AI Chat
Markets
Profile